HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Yorek Selected Research

Proteins (Proteins, Gene)

11/2014Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.
1/2004CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Yorek Research Topics

Disease

26Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 12/2007
23Type 2 Diabetes Mellitus (MODY)
02/2024 - 01/2008
21Diabetic Neuropathies (Diabetic Neuropathy)
01/2021 - 12/2005
15Hyperglycemia
02/2024 - 01/2003
8Obesity
01/2022 - 01/2011
6Diabetes Complications
08/2013 - 02/2002
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016 - 03/2008
3Body Weight (Weight, Body)
01/2020 - 01/2016
3Cardiovascular Diseases (Cardiovascular Disease)
02/2015 - 02/2006
2Hyperalgesia
01/2022 - 06/2006
2Prediabetic State (Prediabetes)
01/2020 - 01/2016
2Mitochondrial Diseases (Mitochondrial Disease)
06/2017 - 11/2014
2Weight Gain
01/2016 - 01/2016
2Insulin Resistance
01/2016 - 10/2011
2Weight Loss (Weight Reduction)
01/2015 - 12/2011
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2009 - 01/2008
2Pancreatitis
07/2006 - 01/2004
1Fibrosis (Cirrhosis)
02/2024
1Atrial Fibrillation
02/2024
1Atrial Remodeling
02/2024
1Atrophy
01/2022
1Polyneuropathies (Polyneuropathy)
01/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Neuroblastoma
01/2021
1Disease Progression
01/2020
1Dyslipidemias (Dyslipidemia)
01/2020
1Fatty Liver
01/2012

Drug/Important Bio-Agent (IBA)

26Streptozocin (Streptozotocin)FDA Link
01/2022 - 01/2003
13Menhaden oilIBA
01/2021 - 01/2012
9Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2015 - 01/2008
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2002
7Neprilysin (Neutral Endopeptidase)IBA
01/2018 - 01/2009
6Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021 - 07/2015
6Fish OilsIBA
01/2020 - 07/2015
6EnalaprilFDA LinkGeneric
06/2017 - 01/2008
6AVE 7688IBA
12/2012 - 01/2009
5Blood Glucose (Blood Sugar)IBA
02/2024 - 09/2014
4Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2020 - 01/2012
4resolvin D1IBA
01/2018 - 07/2015
3LipidsIBA
01/2018 - 01/2008
3Thioctic Acid (Lipoic Acid)IBA
06/2017 - 10/2015
3AntioxidantsIBA
10/2015 - 01/2008
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2015 - 02/2006
3Vasopeptidase InhibitorsIBA
12/2012 - 01/2008
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
06/2006 - 01/2005
2NAD (NADH)IBA
01/2021 - 01/2020
2Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
01/2021 - 08/2013
2Insulin (Novolin)FDA Link
01/2020 - 09/2014
2salicylsalicylic acid (salsalate)IBA
01/2018 - 01/2016
2Angiotensin Receptor AntagonistsIBA
01/2018 - 02/2006
2candoxatrilIBA
11/2016 - 01/2011
2Peroxynitrous Acid (Peroxynitrite)IBA
11/2014 - 12/2007
2Superoxides (Superoxide)IBA
11/2014 - 01/2005
2Proteins (Proteins, Gene)FDA Link
11/2014 - 01/2004
2Acetylcholine (Acetylcholine Chloride)FDA Link
10/2011 - 01/2003
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2008 - 02/2006
2NF-kappa B (NF-kB)IBA
07/2006 - 01/2004
1CalpainIBA
02/2024
1CalciumIBA
02/2024
1Sucrose (Saccharose)IBA
01/2022
1Activating Transcription Factor 4IBA
01/2022
1mitoquinoneIBA
01/2021
1Pyruvaldehyde (Methylglyoxal)IBA
01/2021
1Neuroprotective AgentsIBA
01/2021
1MagnesiumIBA
01/2021
1Unsaturated Dietary FatsIBA
01/2018
1Dietary Fats (Dietary Fat)IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
01/2018
1Docosahexaenoic AcidsIBA
01/2018
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2018
1ML-265IBA
06/2017
1Pyruvate KinaseIBA
06/2017
1Messenger RNA (mRNA)IBA
06/2017
1tempolIBA
04/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2017
1EstersIBA
01/2017
1nicotinamide-beta-ribosideIBA
01/2016
1Nonesterified Fatty Acids (NEFA)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Triglycerides (Triacylglycerol)IBA
01/2016
1CholesterolIBA
01/2016
1Ophthalmic Solutions (Eye Drops)IBA
01/2016
1NADP (NADPH)IBA
01/2016
1EnzymesIBA
11/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2014
1Sodium-Hydrogen Exchanger 1IBA
08/2013
1Lipoxygenase InhibitorsIBA
08/2013
1Sodium-Hydrogen ExchangersIBA
08/2013
1Mitogen-Activated Protein KinasesIBA
08/2013
1AcidsIBA
01/2012
1lardIBA
01/2012
1AdiponectinIBA
01/2012
1baicaleinIBA
12/2011
1Calcitonin Gene-Related PeptideIBA
10/2011

Therapy/Procedure

2Glycemic Control
01/2020 - 09/2014
2Therapeutics
01/2017 - 10/2015
2Injections
01/2017 - 07/2015
2Ligation
07/2006 - 01/2004
1Aftercare (After-Treatment)
01/2020
1Caloric Restriction
12/2011